REGISTRATION AND ABSTRACT SUBMISSIONS NOW OPEN
Keynote speakers
Head of Translational Neurosurgery at University Hospital Erlangen and Head of the MILO-lab at Friedrich-Alexander University of Erlangen-Nuremberg, Freiburg, Germany
Professor Dieter Henrik
Heiland
Professor Ashley joins the VCCC alliance as CEO after eight years as Director of The Preston Robert Tisch Brain Tumor Center, at Duke University Medical Centre, North Carolina in the USA.
Professor David Ashley
Invited speakers
Dr Bingyang Shi
Chair Professor of Nanomedicine at UTS
Professor Cedric Bardy
Group leader of laboratory for Human Neurobiology at SAHMRI and Founding director of Brain Organoid Therapeutics
A/Prof Eng-Siew Koh
Radiation Oncologist at Liverpool Cancer Therapy Centre, Liverpool Hospital
Professor John de Groot
Professor of Neurology and Neurosurgery, and Chief of the Division of Neuro-Oncology at the University of California, San Francisco (UCSF)
Dr Gregory Stein
President and CEO of Curtana Pharmaceuticals
Dr Yanan Zhang
Entrepreneur Fellow and Postdoctoral Researcher, Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland; Co-founder of ZuriEV.
Dr Johannes vom Berg
Group leader at Institute of Laboratory Animal Science, and Co-founder and CSO of InCephalo Therapeutics
Professor Lenka Munoz
Head of the Glioblastoma Drug Discovery Laboratory at the Charles Perkins Centre
Session chairs
Dr Heidi McAlpine - Neurosurgery Registrar, The Royal Melbourne Hospital, PhD Candidate, The Florey, University of Melbourne
Professor Bryan Day - Group Leader of the Sid Faithfull Brain Cancer Laboratory at QIMR Berghofer
Professor Hui Gan - Co-Director of Centre for Research Excellence in Brain Cancer, and Medical Director of Cancer Clinical Trials at Austin Health
A/Professor Lisa Ebert - Group leader at the Centre for Cancer Biology, Adelaide
Professor Stuart Pitson - Head of Molecular Signalling Laboratory at Centre for Cancer Biology, Adelaide